Company Registration No. 11691397 (England and Wales)
Symbiosiz Limited
Unaudited accounts
for the year ended 30 November 2024
Symbiosiz Limited
Unaudited accounts
Contents
Symbiosiz Limited
Company Information
for the year ended 30 November 2024
Directors
Vikram Agarwal
Ruchika Agarwal
Company Number
11691397 (England and Wales)
Registered Office
2 Castle Close
London
SW19 5NH
Accountants
Lilley & Co (UK) Limited
Suite 8
57 High Street
Ibstock
Leicestershire
LE67 6LH
Symbiosiz Limited
Statement of financial position
as at 30 November 2024
Investments
141,892
80,883
Cash at bank and in hand
27,858
136,798
Creditors: amounts falling due within one year
(7,356)
(3,160)
Net current assets
47,238
137,164
Total assets less current liabilities
189,172
219,064
Provisions for liabilities
Net assets
189,164
218,871
Called up share capital
5
5
Profit and loss account
189,159
218,866
Shareholders' funds
189,164
218,871
For the year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2025 and were signed on its behalf by
Vikram Agarwal
Director
Company Registration No. 11691397
Symbiosiz Limited
Notes to the Accounts
for the year ended 30 November 2024
Symbiosiz Limited is a private company, limited by shares, registered in England and Wales, registration number 11691397. The registered office is 2 Castle Close, London, SW19 5NH.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
20% straight line
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
Investments in shares are included at fair value.
Symbiosiz Limited
Notes to the Accounts
for the year ended 30 November 2024
4
Tangible fixed assets
Computer equipment
5
Investments
Other investments
Valuation at 1 December 2023
80,883
Fair value adjustments
15,441
Valuation at 30 November 2024
141,892
Amounts falling due within one year
Accrued income and prepayments
263
263
Other debtors
26,100
2,910
7
Creditors: amounts falling due within one year
2024
2023
Taxes and social security
-
310
Loans from directors
6,776
2,270
Allotted, called up and fully paid:
5 Ordinary shares of £1 each
5
5
Symbiosiz Limited
Notes to the Accounts
for the year ended 30 November 2024
9
Average number of employees
During the year the average number of employees was 2 (2023: 2).